JPRN-UMIN000027904
Completed
Phase 1
A proof-of-concept clinical trial to evaluate the efficacy and safety of combined use of cefadroxil and tyrosine kinase inhibitors in minimal residual disease-positive patients with chronic phase chronic myelogenous leukemia - The efficacy and safety of TKI combined CDX for CML-CP
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University.0 sites0 target enrollmentJuly 15, 2017
ConditionsChronic myelogenous leukemia
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Chronic myelogenous leukemia
- Sponsor
- Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University.
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) History of shock against CDX (2\) Infectious mononucleosis (3\) Hypersensitivity against cephalosporin and penicillin antimicrobial agents (4\) Renal insufficiency (CCr;less than 50ml/min.) (5\) Difficulty of oral intake and receiving the parental nutrition (6\) History of receiving stem cell transplantation (7\) Cardiac dysfunction (necessary of medication for arrhythmia, ischemic cardiac disease, heart failure and cardiomyopathy) (8\) Pregnancy, nursing or possibly pregnant women (9\) Attempt to get the child and no will of contraception (10\) Patients received cephalosporin within twelve weeks ago before this trial (11\) Patients participated other trail study and took trial drugs. (12\) No indication for this study as judged by physicians in charge
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A clinical trial to evaluate the feasibility of patient-specific perigastric lymph node dissection (tailored surgery) using indocyanine green fluorescence navigation in gastric cancer surgeryDiseases of the digestive systemKCT0005760Seoul National University Hospital200
Recruiting
Not Applicable
The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity.Retinopathy of prematurityJPRN-UMIN000018069Gunma University Hospital Department of Ophthalmology4
Not yet recruiting
Not Applicable
â?? Ayurvedic intervention in the management of COVID-19 positive childrenâ??Health Condition 1: B342- Coronavirus infection, unspecifiedHealth Condition 2: B342- Coronavirus infection, unspecifiedHealth Condition 3: R070- Pain in throatHealth Condition 4: R070- Pain in throatCTRI/2021/01/030529Ch Brahm Prakash Ayurved Charak Sansthan
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic DermatitisDiseases of the skin and subcutaneous tissueKCT0003177DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA14
Active, not recruiting
Not Applicable
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE